Participants 111 136 4
granulocytopenic patients
Participants 413 438 4
granulocytopenic patients
Participants 440 550 9
Patients were stratified into two groups: favorable-prognosis, group 1 (carcinoma, lymphoma, multiple myeloma)
Participants 552 631 9
or unfavorable-prognosis, group 2 (acute leukemia, bone marrow transplantation)
